17th International Conference on Alzheimer’s Drug Discovery

17th International Conference on Alzheimer’s Drug Discovery

September 12-13, 2016

 

Hyatt Regency
Jersey City, NJ

This annual conference brings together academic and industry scientists intent on accelerating the development of innovative treatments for Alzheimer’s disease and related dementias. The ADDF's funded investigators and top-level scientists in the field will present on their current research progress and stimulate discussion. The conference offers ample opportunity for collaboration and partnering.

This Year's Speakers

• Dirk Beher, Aceneuron
• Elizabeth Bradshaw, Brigham and Women's Hospital
• Carol Colton, Duke University Medical Center
• Mari DeMarco, University of British Columbia
• Pontus Forsell, AlzeCure Foundation
• Michael Gold, PPD
• Atticus Hainsworth, St. George, University of London
• Ihab Hajjar, Emory University
• Mansuo Hayashi, Eli Lilly and Company
• Lawrence Honig, Columbia University
• Edward Huey, Columbia University
• Berkley Lynch, Rodin Therapeutics
• Alexandros Makriyannis, Northeastern University
• Yukari Perrella, Yuma Therapeutics
• Jerri Rook, Vanderbilt Center of Neuroscience Drug Discovery
• Sharon Rosenzweig-Lipson, AgeneBio
• Stephen Salton, Icahn School of Medicine at Mount Sinai
• Grace Stutzmann, Rosalind Franklin University of Science and Medicine
• Paul Thompson, University of Massachusetts
• Raymond Scott Turner, Georgetown University
• Shijun Zhang, Virginia Commonwealth University
• Danna Zimmer, University of Maryland School of Medicine


Get Updates on the ADDF's Upcoming Conferences and Meetings

Sign up to receive news by email.